Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy
/wp-content/themes/awp-enfold/blank.png00/wp-content/themes/awp-enfold/blank.png2023-01-01 00:00:002023-01-01 00:00:00Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy
